You just read:

Clinical Trial Investigates Orbsen Therapeutics' ORBCEL-C™ Immunotherapy as Treatment for Two Autoimmune Liver Diseases

News provided by

Orbsen Therapeutics

08 Apr, 2019, 10:02 BST